疼痛管理デバイス市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年11月

疼痛管理デバイス市場:タイプ(神経刺激、SCS、TENS、RFアブレーション、輸液ポンプ)、用途(神経障害、がん、顔面、MSK、片頭痛)、購入方法(OTC、処方ベース)、地域(北米、ヨーロッパ、APAC)- 2026年までの世界予測

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) – Global Forecasts to 2026

ページ数 245
図表数 242
種別 英文調査報告書

目次  お問合せ

The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years.

Neurostimulation devices to hold the largest segment of the market
Based on type, the pain management devices market is segmented into neurostimulation devices, infusion pumps, and ablation devices. In 2020, the neurostimulation segment accounted for 58.0% of the pain management devices market. Neurostimulation devices provide pain relief by disrupting pain signals traveling between the spinal cord and the brain. These devices can be either implantable or non-implantable in nature. Neuromodulation devices are further classified into transcutaneous electrical nerve stimulators (TENS) and spinal cord stimulators. The large share and high growth of this segment is attributed to advantages of neuromodulation as compared to alternative therapies for managing chronic pain, its long-term cost effectivity and technological developments in the neurostimulation devices segment.

Neuropathic pain to hold the largest share of the applications market
Based on application, the pain management devices market is segmented into neuropathic pain, musculoskeletal pain, cancer pain, facial pain & migraine, and other applications. The neuropathic pain segment accounted for the largest market share of 31.4% in 2020. The presence of substantial clinical evidences in the favor of high efficacy of pain management devices in neuropathic pain treatment, development of novel neuropathic pain management devices, rising aging population across the globe (geriatric population is at high risk of neuropathic pain due to the increased incidence of neuropathic pain associated with many age-related diseases), side effects of drugs used to treat neuropathic pain, and availability of reimbursement are fueling the adoption of pain management devices for neuropathic pain treatment are the major factors contributing to the growth of the pain management devices market for neuropathic pain applications.

The US to dominate the pain management devices market in North America
North America dominated the pain management devices market, with a share of 52.3% in 2020, followed by Europe and the Asia Pacific, Latin America, and Middle East & Africa. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The pain management devices market in the US is expected to offer growth opportunities in the coming years owing to the increasing adoption of pain management devices in ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 60%, Tier 2 – 30%, and Tier 3 – 10% • By Designation: Director-level – 30%, C-level – 50%, and Others – 20% • By Region: North America – 45%, Europe – 15%, APAC –25%, Rest of the World –15%
Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.

Research Coverage
This report studies the pain management devices market based on type, mode of purchase, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


目次

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 31
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED FOR THE STUDY 32
1.3.3 CURRENCY 32
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH APPROACH 35
2.2 RESEARCH METHODOLOGY DESIGN 35
FIGURE 1 PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN 35
2.2.1 SECONDARY RESEARCH 36
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY DATA 38
FIGURE 2 PRIMARY SOURCES 38
2.2.2.1 Key data from primary sources 39
2.2.2.2 Key industry insights 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
2.3 MARKET SIZE ESTIMATION 41
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 42
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020) 43
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021–2026) 45
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 10 TOP-DOWN APPROACH 46
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 47
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 47
2.5 MARKET SHARE ANALYSIS 48
2.6 ASSUMPTIONS FOR THE STUDY 48
2.7 RISK ASSESSMENT 49
TABLE 1 RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET 49
2.8 LIMITATIONS 49
2.8.1 METHODOLOGY-RELATED LIMITATIONS 49
2.8.2 SCOPE-RELATED LIMITATIONS 49
3 EXECUTIVE SUMMARY 50
FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 50
FIGURE 13 NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 51
FIGURE 14 INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 51
FIGURE 15 ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 52
FIGURE 16 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 52
FIGURE 17 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE,
2021 VS. 2026 (USD MILLION) 53
FIGURE 18 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET 54
4 PREMIUM INSIGHTS 56
4.1 PAIN MANAGEMENT DEVICES MARKET OVERVIEW 56
FIGURE 19 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER 56
4.2 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020) 57
FIGURE 20 NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 2020 57
4.3 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX 58
FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 58
4.4 REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET 59
FIGURE 22 NORTH AMERICA DOMINATED THE MARKET IN 2020 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 23 PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
5.2.1 MARKET DRIVERS 61
5.2.1.1 Rising demand for chronic pain management in home care settings 61
5.2.1.2 Growing number of surgical procedures performed 61
5.2.1.3 Rising prevalence of neurological disorders 62
5.2.1.3.1 Growing incidence of sports injuries and cancer 62
TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019 63
5.2.1.4 Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries 63
5.2.2 MARKET RESTRAINTS 64
5.2.2.1 Product recalls 64
5.2.2.2 High procedural and purchase cost of pain management devices 64
5.2.3 MARKET OPPORTUNITIES 65
5.2.3.1 High growth opportunities in emerging countries 65
TABLE 3 RISING INCOME LEVELS IN EMERGING COUNTRIES 65
5.2.3.2 Expanding base of pain management clinics/centers across the globe 66
5.2.3.3 Use of pain medications as the first line of treatment for pain management 66
5.2.3.4 Stringent regulatory guidelines delay the adoption of novel devices 67
TABLE 4 PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE 67
5.3 REGULATORY LANDSCAPE 68
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES 68
5.3.1 NORTH AMERICA 69
5.3.1.1 US 69
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 69
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 70
5.3.1.2 Canada 70
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 71
5.3.2 EUROPE 72
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 73
5.3.3 ASIA PACIFIC 74
5.3.3.1 Japan 74
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 74
5.3.3.2 China 74
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75
5.3.3.3 India 76
FIGURE 27 LATIN AMERICA: REGULATORY SCENARIO 77
5.3.3.4 Brazil 77
FIGURE 28 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES 78
TABLE 11 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 78
5.3.3.5 Mexico 79
FIGURE 29 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES 79
TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 80
5.4 VALUE CHAIN ANALYSIS 80
FIGURE 30 PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS 81
5.5 SUPPLY CHAIN ANALYSIS 81
FIGURE 31 PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS 82
5.6 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 83
5.6.1 THREAT FROM NEW ENTRANTS 84
5.6.2 THREAT FROM SUBSTITUTES 84
5.6.3 BARGAINING POWER OF SUPPLIERS 84
5.6.4 BARGAINING POWER OF BUYERS 85
5.6.5 COMPETITIVE RIVALRY 85
5.7 INDUSTRY TRENDS 85
5.7.1 WEARABLE DEVICES 85
5.7.2 RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS 85
5.8 TRADE ANALYSIS 86
5.8.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES 86
TABLE 14 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,
2016–2020 (USD BILLION) 86
5.9 COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET 86
6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE 88
6.1 INTRODUCTION 89
TABLE 15 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 89
6.2 NEUROSTIMULATION DEVICES 89
TABLE 16 NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 17 NEUROSTIMULATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 90
6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES 90
6.2.1.1 Extensive use in healthcare, low cost, and ease of use will favor market growth 90
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 91
6.2.2 SPINAL CORD STIMULATION 91
6.2.2.1 Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS 91
TABLE 19 SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 92
6.3 INFUSION PUMPS 92
6.3.1 HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT 92
TABLE 20 INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 21 INFUSION PUMPS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 93
6.3.2 INTRATHECAL INFUSION PUMPS 93
TABLE 22 INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 94
6.3.3 EXTERNAL INFUSION PUMPS 94
TABLE 23 EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 95
6.4 ABLATION DEVICES 95
TABLE 24 ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 25 ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 96
6.4.1 RF ABLATION DEVICES 96
TABLE 26 RF ABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 97
6.4.2 CRYOABLATION DEVICES 97
TABLE 27 CRYOABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 98
7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION 99
7.1 INTRODUCTION 100
TABLE 28 PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 100
7.2 NEUROPATHIC PAIN 100
7.2.1 HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN 100
TABLE 29 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 101
7.3 CANCER PAIN 101
TABLE 30 CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 102
7.4 FACIAL PAIN & MIGRAINE 102
TABLE 31 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 104
7.5 MUSCULOSKELETAL PAIN 104
TABLE 32 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 105
7.6 OTHER APPLICATIONS 105
TABLE 33 OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 106
8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE 107
8.1 INTRODUCTION 108
TABLE 34 PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 108
8.2 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES 108
8.2.1 OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES 108
TABLE 35 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION) 109
8.3 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES 109
TABLE 36 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION) 110

9 PAIN MANAGEMENT DEVICES MARKET, BY REGION 111
9.1 INTRODUCTION 112
FIGURE 32 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 112
TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 113
9.2 NORTH AMERICA 113
FIGURE 33 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT 114
TABLE 38 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 39 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 40 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 41 NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 42 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 43 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION) 116
TABLE 44 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 116
9.2.1 THE US 117
9.2.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market 117
TABLE 45 KEY MACROINDICATORS FOR THE US 117
TABLE 46 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 47 US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 48 US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 49 US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 50 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 119
TABLE 51 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 119
9.2.2 CANADA 120
9.2.2.1 Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada 120
TABLE 52 KEY MACROINDICATORS FOR CANADA 120
TABLE 53 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 54 CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 55 CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 56 CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 122
TABLE 57 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 122
TABLE 58 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 122
9.3 EUROPE 123
TABLE 59 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 60 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 61 EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 62 EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 63 EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 64 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 126
TABLE 65 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 126
9.3.1 GERMANY 126
9.3.1.1 Presence of leading pain management device manufacturers to drive market growth in Germany 126
TABLE 66 KEY MACROINDICATORS FOR GERMANY 127
TABLE 67 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 68 GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 69 GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 70 GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 71 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 129
TABLE 72 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 129
9.3.2 FRANCE 130
TABLE 73 KEY MACROINDICATORS FOR FRANCE 130
TABLE 74 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 75 FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 76 FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 77 FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 78 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 132
TABLE 79 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 132
9.3.3 THE UK 133
9.3.3.1 High burden of chronic pain in the country to propel the
growth of the pain management devices market 133
TABLE 80 KEY MACROINDICATORS FOR THE UK 134
TABLE 81 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 82 UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 83 UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 84 UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 85 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 135
TABLE 86 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 136
9.3.4 ITALY 136
9.3.4.1 Growing demand for cost-effective home care services to support market growth 136
TABLE 87 KEY MACROINDICATORS FOR ITALY 136
TABLE 88 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 89 ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 90 ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 91 ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 92 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 138
TABLE 93 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 139
9.3.5 SPAIN 139
9.3.5.1 Rising prevalence of cancer to support the market for pain management devices market in Spain 139
TABLE 94 KEY MACROINDICATORS FOR SPAIN 140
TABLE 95 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 96 SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 97 SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 98 SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 99 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 141
TABLE 100 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 142
9.3.6 REST OF EUROPE 142
TABLE 101 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 102 ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 103 ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 104 ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 105 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 106 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 144
9.4 ASIA PACIFIC 145
FIGURE 34 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT 146
TABLE 107 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 108 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 109 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 110 ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 111 ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 112 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 148
TABLE 113 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 149
9.4.1 JAPAN 149
9.4.1.1 Large geriatric population in the country is driving the demand for infusion pumps 149
TABLE 114 KEY MACRO INDICATORS FOR JAPAN 150
TABLE 115 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 116 JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 117 JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 118 JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 119 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 151
TABLE 120 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 152
9.4.2 CHINA 152
9.4.2.1 Growing investments in healthcare infrastructure development in the country to drive market growth in China 152
TABLE 121 KEY MACRO INDICATORS FOR CHINA 153
TABLE 122 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 123 CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 124 CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 125 CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 126 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 154
TABLE 127 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 155
9.4.3 INDIA 155
9.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for pain management devices market 155
TABLE 128 KEY MACRO INDICATORS FOR INDIA 156
TABLE 129 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 130 INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 131 INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 132 INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 133 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 134 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 158
9.4.4 REST OF ASIA PACIFIC 158
9.4.4.1 High prevalence of chronic diseases in the region to drive the market for pain management devices 158
FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019) 159
TABLE 135 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND) 159
FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018) 159
FIGURE 37 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION) 160
TABLE 136 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 137 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 138 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 139 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 140 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION) 161
TABLE 141 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 162
9.5 LATIN AMERICA 162
TABLE 142 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 143 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 144 LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 145 LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 146 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION) 164
TABLE 147 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 164
9.6 MIDDLE EAST AND AFRICA 165
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 165
TABLE 148 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 149 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 150 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 151 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 152 MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION) 167
TABLE 153 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 167
10 COMPETITIVE LANDSCAPE 168
10.1 OVERVIEW 168
FIGURE 38 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021) 169
10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 170
FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET 170
10.3 MARKET SHARE ANALYSIS 170
FIGURE 40 PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020 171
10.4 COMPANY EVALUATION QUADRANT 172
10.4.1 STARS 172
10.4.2 EMERGING LEADERS 172
10.4.3 PERVASIVE PLAYERS 172
10.4.4 PARTICIPANTS 173
FIGURE 41 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020) 173
10.5 COMPANY EVALUATION QUADRANT FOR START-UPS 174
10.5.1 PROGRESSIVE COMPANIES 174
10.5.2 DYNAMIC COMPANIES 174
10.5.3 STARTING BLOCKS 174
10.5.4 RESPONSIVE COMPANIES 174
FIGURE 42 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 175
10.6 COMPANY PRODUCT FOOTPRINT 176
TABLE 154 PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET 176
10.7 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET 177
TABLE 155 GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020) 177
10.8 COMPETITIVE SCENARIO 178
10.8.1 PRODUCT LAUNCHES 178
TABLE 156 PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021) 178
10.8.2 DEALS 181
TABLE 157 DEALS (JANUARY 2018–JUNE 2021) 181
10.8.3 OTHER DEVELOPMENTS 183
TABLE 158 OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021) 183
11 COMPANY PROFILES 184
11.1 KEY PLAYERS 184
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 MEDTRONIC 184
TABLE 159 MEDTRONIC PLC: BUSINESS OVERVIEW 184
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 185
11.1.2 ABBOTT LABORATORIES 188
TABLE 160 ABBOTT LABORATORIES: BUSINESS OVERVIEW 188
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT 188
TABLE 161 ABBOTT LABORATORIES: PRODUCT OFFERINGS 189
11.1.3 BOSTON SCIENTIFIC CORPORATION 191
TABLE 162 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 191
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 192
TABLE 163 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS 193
11.1.4 STRYKER CORPORATION 195
TABLE 164 STRYKER: BUSINESS OVERVIEW 195
FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT 196
TABLE 165 STRYKER: PRODUCT OFFERINGS 196
11.1.5 BECTON, DICKINSON AND COMPANY 198
TABLE 166 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 198
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 199
11.1.6 B. BRAUN MELSUNGEN AG 202
TABLE 167 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 202
FIGURE 48 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 203
11.1.7 BAXTER INTERNATIONAL INC. 207
TABLE 168 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 207
FIGURE 49 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020) 208
11.1.8 AVANOS MEDICAL, INC. 211
TABLE 169 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW 211
FIGURE 50 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020) 212
11.1.9 TELEFLEX, INC. 214
TABLE 170 TELEFLEX, INC.: BUSINESS OVERVIEW 214
FIGURE 51 TELEFLEX, INC.: COMPANY SNAPSHOT (2020) 215
11.1.10 SMITHS MEDICAL 216
TABLE 171 SMITHS MEDICAL: BUSINESS OVERVIEW 216
FIGURE 52 SMITHS MEDICAL: COMPANY SNAPSHOT (2020) 217
11.1.11 NIPRO CORPORATION 219
TABLE 172 NIPRO CORPORATION: BUSINESS OVERVIEW 219
FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2019) 220
11.1.12 MOOG INC. 222
TABLE 173 MOOG INC.: BUSINESS OVERVIEW 222
FIGURE 54 MOOG INC.: COMPANY SNAPSHOT (2020) 223
11.1.13 ATRICURE 225
TABLE 174 ATRICURE: BUSINESS OVERVIEW 225
FIGURE 55 ATRICURE: COMPANY SNAPSHOT 225
TABLE 175 ATRICURE: PRODUCT OFFERINGS 226
11.1.14 NEVRO CORP. 227
TABLE 176 NEVRO CORP: BUSINESS OVERVIEW 227
FIGURE 56 NEVRO CORP.: COMPANY SNAPSHOT 227
TABLE 177 NEVRO CORP: PRODUCT OFFERINGS 228
11.1.15 MICREL MEDICAL DEVICES SA 229
TABLE 178 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW 229
11.1.16 MINDRAY MEDICAL INTERNATIONAL LIMITED 231
TABLE 179 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 231
11.1.17 SHENZHEN MEDRENA BIOTECH CO., LTD. 233
TABLE 180 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW 233
11.1.18 EPIC MEDICAL 234
TABLE 181 EPIC MEDICAL: BUSINESS OVERVIEW 234
11.1.19 BIONESS 235
11.1.20 SOTERIX MEDICAL 236
11.2 OTHER PLAYERS 237
11.2.1 INFUTRONIX SOLUTIONS LLC 237
TABLE 182 INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW 237
11.2.2 GIMER MEDICAL 239
11.2.3 BLUEWIND MEDICAL 239
11.2.4 NEURONANO 239
11.2.5 MICROTRANSPONDER 240
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 241
12.1 DISCUSSION GUIDE 241
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245
12.3 AVAILABLE CUSTOMIZATIONS 247
12.4 RELATED REPORTS 248
12.5 AUTHOR DETAILS 249


お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ区分(必須)

    お問合せ内容(必須)

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com